Articles related to MYASTHENIA GRAVIS
Cleveland Clinic Journal of Medicine
What are the Treatment Options for Myasthenia Gravis if First-line Agents Fail?
Consider immunosuppressive therapy in patients on adequate acetylcholinesterase inhibitor therapy who do not demonstrate significant benefit. This article discusses the assessment of therapeutic failure, steroidal therapy, when to consider nonsteroidal anti-inflammatory therapy, and recommendations for monitoring treatment.
Neurology February 28th 2023
Complement and the Prothrombotic State
Parallels and distinct features among paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) are discussed against the background of thrombosis, complement activation via eculizumab, and potential complement diagnostic and therapeutic avenues.
Hematology April 5th 2022